Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71601 - 71625 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	MCC	4163	downregulated	Silicon Dioxide results in decreased expression of MCC mRNA	5q22.2	A24196
Silicon dioxide	Approved	MCF2L	23263	downregulated	Silicon Dioxide analog results in decreased expression of MCF2L mRNA	13q34	A24195
Silicon dioxide	Approved	MCF2L-AS1	100289410	downregulated	Silicon Dioxide analog results in decreased expression of MCF2L-AS1 mRNA	13q34	A24195
Silicon dioxide	Approved	MCFD2	90411	upregulated	Silicon Dioxide analog results in increased expression of MCFD2 mRNA	2p21	A24195
Silicon dioxide	Approved	MCM10	55388	downregulated	Silicon Dioxide analog results in decreased expression of MCM10 mRNA	10p13	A24194
Silicon dioxide	Approved	MCM4	4173	downregulated	Silicon Dioxide analog results in decreased expression of MCM4 mRNA	8q11.21	A24194
Silicon dioxide	Approved	MCM7	4176	downregulated	Silicon Dioxide results in decreased expression of MCM7 mRNA	7q22.1	A24196
Silicon dioxide	Approved	MCOLN3	55283	upregulated	Silicon Dioxide analog results in increased expression of MCOLN3 mRNA	1p22.3	A24195
Silicon dioxide	Approved	MCRS1	10445	downregulated	Silicon Dioxide results in decreased expression of MCRS1 mRNA	12q13.12	A24196
Silicon dioxide	Approved	MCTP1	79772	upregulated	Silicon Dioxide analog results in increased expression of MCTP1 mRNA	5q15	A24195
Silicon dioxide	Approved	MCTP1	79772	upregulated	Silicon Dioxide results in increased expression of MCTP1 mRNA	5q15	A24196
Silicon dioxide	Approved	MCU	90550	downregulated	Silicon Dioxide analog results in decreased expression of MCU mRNA	10q22.1	A24195
Silicon dioxide	Approved	MDGA1	266727	downregulated	Silicon Dioxide analog results in decreased expression of MDGA1 mRNA	6p21.2	A24195
Silicon dioxide	Approved	MDK	4192	downregulated	Silicon Dioxide analog results in decreased expression of MDK mRNA	11p11.2	A24195
Silicon dioxide	Approved	MDM1	56890	downregulated	Silicon Dioxide results in decreased expression of MDM1 mRNA	12q15	A24196
Silicon dioxide	Approved	MED10	84246	upregulated	Silicon Dioxide analog results in increased expression of MED10 mRNA	5p15.31	A24195
Silicon dioxide	Approved	MED18	54797	downregulated	Silicon Dioxide analog results in decreased expression of MED18 mRNA	1p35.3	A24195
Silicon dioxide	Approved	MED8	112950	upregulated	Silicon Dioxide analog results in increased expression of MED8 mRNA	1p34.2	A24195
Silicon dioxide	Approved	MEDAG	84935	upregulated	Silicon Dioxide analog results in increased expression of MEDAG mRNA	13q12.3	A24194
Silicon dioxide	Approved	MEGF10	84466	upregulated	Silicon Dioxide analog results in increased expression of MEGF10 mRNA	5q23.2	A24194
Silicon dioxide	Approved	MEGF6	1953	upregulated	Silicon Dioxide analog results in increased expression of MEGF6 mRNA	1p36.32	A24195
Silicon dioxide	Approved	MEGF9	1955	downregulated	Silicon Dioxide analog results in decreased expression of MEGF9 mRNA	9q33.2	A24195
Silicon dioxide	Approved	MEIG1	644890	downregulated	Silicon Dioxide analog results in decreased expression of MEIG1 mRNA	10p13	A24195
Silicon dioxide	Approved	MEIS2	4212	downregulated	Silicon Dioxide analog results in decreased expression of MEIS2 mRNA	15q14	A24195
Silicon dioxide	Approved	MEIS3	56917	downregulated	Silicon Dioxide analog results in decreased expression of MEIS3 mRNA	19q13.32	A24195

Displaying entries 71601 - 71625 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability